Page last updated: 2024-12-10

1-salicylate glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1-Salicylate Glucuronide: What it is and why it's important

**1-Salicylate glucuronide** is a **metabolite** of **salicylic acid**, the active ingredient in aspirin. It's formed in the liver via a process called **glucuronidation**, where a molecule of glucuronic acid is attached to salicylate.

**Here's why it's important for research:**

* **Pharmacokinetic studies:** Understanding the metabolism of salicylate is crucial for **determining the pharmacokinetic properties** of aspirin, such as its absorption, distribution, metabolism, and excretion. This knowledge is essential for optimizing drug dosage and minimizing side effects.

* **Toxicity studies:** Salicylate glucuronide formation is important for **understanding the toxicity of salicylate**. Since glucuronidation helps to detoxify salicylate, measuring levels of this metabolite can indicate the efficiency of the detoxification process and the potential for toxicity.

* **Disease research:** 1-Salicylate glucuronide levels can also be studied in the context of various diseases. For example, **reduced glucuronidation** has been linked to **liver disease** and **certain genetic disorders**, making it a potential biomarker for these conditions.

* **Clinical applications:** Measuring salicylate glucuronide levels in patients can help clinicians assess **the effectiveness of aspirin therapy** and monitor for potential toxicity. This is especially important for patients taking high doses of aspirin or those with compromised liver function.

* **Drug interactions:** Certain drugs can inhibit or induce glucuronidation, affecting the levels of 1-salicylate glucuronide and potentially impacting the efficacy and safety of aspirin therapy.

**Overall, 1-salicylate glucuronide is a valuable tool for researchers and clinicians seeking to understand the metabolism, toxicity, and clinical implications of aspirin. Its importance stems from its role in the detoxification of salicylate and its potential as a biomarker for various conditions.**

1-salicylate glucuronide: urinary metabolite of salicylic acid; RN given refers to (beta-D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-salicylate glucuronide : A beta-D-glucosiduronic acid that is the glucuronide conjugate of salicyclic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3084023
CHEMBL ID1371375
CHEBI ID73961
SCHEMBL ID21594800
MeSH IDM0142920

Synonyms (27)

Synonym
beta-d-glucopyranosiduronic acid, 2-carboxyphenyl
salicylphenolic glucuronide
salicyl phenolic glucuronide
7695-70-7
1-salicylate glucuronide
phenolic sa glucuronide
salicylic glucuronide
salicylic acid glucuronide
(2s,3s,4s,5r,6s)-6-(2-carboxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
2-carboxyphenyl beta-d-glucopyranosiduronic acid
CHEBI:73961 ,
salicylic acid beta-d-o-glucuronide
DTXSID20227737
W-203760
salicylic acid phenolic d-glucuronide
JSCWDKKMLIQCMR-CDHFTJPESA-N
.beta-d-glucopyranosiduronic acid, 2-carboxyphenyl
salicylic acid .beta.-d-o-glucuronide
salicyl glucuronide
CHEMBL1371375
1-salicylic acid glucuronide
SCHEMBL21594800
Q27144282
salicylic acid ?-d-o-glucuronide
salicylic acid beta -d-o-glucuronide
PD150553
AKOS040755856

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" At the end of each 2-week dosage period, plasma and urine were collected over a dosage interval for the estimation of various pharmacokinetic parameters."( Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.
Bochner, F; Cleland, LG; Graham, GG; Imhoff, DM; Polverino, A; Rolan, PE; Tregenza, RA, 1987
)
0.27

Dosage Studied

ExcerptRelevanceReference
"The pharmacokinetics of salicyl phenolic glucuronide (SPG) and other salicylic acid (SA) metabolites were studied at three aspirin dosage regimens in eight patients with rheumatoid arthritis."( Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.
Bochner, F; Cleland, LG; Graham, GG; Imhoff, DM; Polverino, A; Rolan, PE; Tregenza, RA, 1987
)
0.27
" Effects of ASA dosage on the metabolic profile have not been fully understood."( Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile.
Duan, JA; Guo, JM; Li, JP; Liu, Y; Shang, EX; Tang, ZS; Zhao, BC; Zhao, J; Zhu, ZH, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
beta-D-glucosiduronic acidA glucosiduronic acid resulting from the formal condensation of any substance with beta-D-glucuronic acid to form a glycosidic bond.
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]